Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

PerkinElmer Introduces Novel Research Tools at SLAS 2014

Published: Monday, January 27, 2014
Last Updated: Monday, January 27, 2014
Bookmark and Share
PerkinElmer Inc. introduced several novel products at SLAS2014, including the Opera® Phenix™ high content screening system, JANUS® chemagic nucleic acid workstation.

"We are excited to participate in this important event for our industry as we continue to listen and learn from our customers, helping advance transformative science and build upon a legacy of innovation in automation, detection and screening solutions,” said Jim Corbett, President, Life Sciences and Technology, PerkinElmer. "Advances in phenotyping complex cellular models and innovations in genomics, particularly rapid, high throughput nucleic acid extraction, offer new tools to accelerate our understanding of cancer and other life threatening diseases, as well as enable customers to bring better, more effective therapeutics to market." 

PerkinElmer products on display at SLAS 2014 include:

• Opera® Phenix, a next generation confocal high content screening system, is designed to reliably discriminate phenotypes of complex cellular models, such as primary cells and 3D microtissue, which are more indicative of human biology. Accurate, reliable characterization of cellular processes can further scientists’ understanding of cancer cell morphology and therefore the development of targeted cancer treatments. The system’s patented Synchony Optics™ control excitation to eliminate unwanted crosstalk in the sample, resulting in better sensitivity but without compromising speed. Data generated using the Phenix® imaging system can be processed seamlessly with PerkinElmer’s Harmony® High Content Imaging and Analysis Software, an intuitive workflow-based interface optimized for processing large volumes of data. 

• The JANUS® chemagic automated nucleic acid workstation offers high throughput DNA and RNA extraction with four times the yield and twice the throughput of alternate technologies. A fully integrated system, this workstation combines best-in-class magnetic bead nucleic acid isolation technology with a fully-supported automated liquid handler to rapidly accelerate the extraction process. Standardized protocols are designed for volume ranges of 10µl up to 4mL, resulting in reproducible, high throughput extraction from a variety of blood input sample types for downstream processing including PCR/qPCR, Sanger or next gen sequencing, microarrays and genotyping.

• Dedicated AlphaLISA® immunoassay kits for isotyping human and mouse antibodies provide high specificity and low cross-reactivity between isotypes, without compromising sensitivity or throughput. 

• AlphaLISA kits and toolbox reagents for metabolic disease research with biomarkers including Glucagon, Insulin, Leptin, C-peptide, and FGF21

• AlphaLISA kits for cell-based epigenetic ubiquitination which enable scientists to fully validate the mechanism of action of drugs thought to act on methyltransferase (eg. EZH2) or demethylase (eg. JMJD2A, JMJD3) enzymes in cell-based assays by testing their capacity to modulate H2a ubiquitination. These kits allow considerable time-savings over Enzyme-linked immunosorbent assay (ELISA) technology, commonly used to perform immunoassays. 

The above products are for research use only and not for use in diagnostic procedures.

• SciStream™, new software enabling the easy import of plate-based and other forms of instrument data into the TIBCO Spotfire® Analytics and Visualization Platform.  SciStream unlocks the power of TIBCO Spotfire software for users of plate readers, high content imaging systems and other instruments, enabling researchers to easily and dynamically visualize their experimental data, metadata and plate layouts with unprecedented speed and interactivity.  Faster visualization and analysis in TIBCO Spotfire software leads to scientific insights much more quickly than using traditional tools for assay development as well as large screening campaigns.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PerkinElmer and MGH Pathology Collaborate
Collaboration to develop a complete sequencing informatics system for cancer research.
Wednesday, September 12, 2012
PerkinElmer Expands Reagent Portfolio for Faster Identification of Epigenetic Drug Candidates
The company announced the launch of four new cellular assay kits to help identify and characterize possible drug candidates targeting epigenetic enzymes related to key disease states.
Tuesday, February 07, 2012
PerkinElmer to Acquire Caliper Life Sciences
PerkinElmer, Inc. announces that it has signed a definitive agreement to acquire Caliper Life Sciences, Inc. for a total net purchase price of approximately $600 million.
Wednesday, September 21, 2011
Scientific News
Lung Repair and Regeneration Gene Discovered
New role for hedgehog gene offers better understanding of lung disease.
3 Ways Viruses Have Changed Science for the Better
Viruses are really good at what they do, and we’ve been able to harness their skills to learn about – and potentially improve – human health in several ways.
Mixed Up Cell Transportation Key Piece of ALS and Dementia Puzzle
Researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Five New Genetic Variants Linked to Brain Cancer Identified
The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Fatty Liver Disease and Scarring Have Strong Genetic Component
Researchers say that hepatic fibrosis, which involves scarring of the liver that can result in dysfunction and, in severe cases, cirrhosis and cancer, may be as much a consequence of genetics as environmental factors.
Specific Variations in RNA Splicing Linked to Breast Cancer
Researchers have identified cellular changes that may play a role in converting normal breast cells into tumors. Targeting these changes could potentially lead to therapies for some forms of breast cancer.
Finding Links and Missing Genes
A catalogue of large-scale genetic changes around the world.
Scientists Test New Gene Therapy for Vision Loss from a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos